AI doctor concept
Adobe
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Beamtree (ASX:BMT) has inked a A$600,000 bundle of contracts across Australia, Canada, and the U.K. to reportedly automate hospital clinical coding operations.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Clinical coding refers to the standardised lexicon of alphanumeric codes used by hospitals around the world to effectively ‘shorthand’ specific diagnoses and other patient datum.

According to Beamtree – which didn’t provide a source – clinical coding errors by human hand cost hospital reimbursements some A$20B globally.

“Each contract is subject to the usual rights of termination for non-performance,” Beamtree added on Monday.

Shares jumped 8.7% to 25cps, showing a healthy reaction, however, that was on turnover of only $2,000 according to a third-party service porting Morningstar data. In other words: The stock is straddled by illiquidity.

This isn’t Beamtree’s first foray into the medical space. It recently expanded into Saudi Arabia with the same modus operandi.

The big question, of course, will be if Beamtree’s AI is any good. Even the “AI” models advertised as being the most advanced on the market frequently make mistakes. True believers generally try to avoid talking about that.

Beamtree, of course, sees a way for hospitals to spend more time on care, by automating manual data entry jobs. A handy pitch, but if they can pull it off, one that probably does pose a chunky value proposition.

More market news

51st State: What is Trump’s endgame with tariffs – and what will it mean for Canada?

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

“Autonomous coding will be a material driver of our future growth and these contract wins provide a foundation for this pioneering product,” Beamtree CEO Marek Stepniak said.

“I want to thank our customers in supporting this innovation.”

By that, Stepniak means the hospitals adopting the tech. Make of that what you will.

BMT last traded at 25cps.

Join the discussion: See what HotCopper users are saying about Beamtree and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

BMT by the numbers
More From The Market Online
AUS CHART CONCEPT

Week 13 Wrap: ASX nearly recovers 8000pts, then doesn’t – thanks Trump!

Welcome to the end of another week! The ASX nearly got back to 8,000pts where it…
Sandoz logo

Avecho clocks $4.7M payment from pharma giant Sandoz for CBD capsule licence

Avecho (ASX:AVE) has received a US$3M (A$4.7M) payment from pharma heavyweight Sandoz in exchange for the…
The Market Online Video

HotCopper Highlights for Week 13 – Opthea, Reject Shop, Bellevue & more!

Good Afternoon and welcome to HotCopper Highlights, I’m Jonathon Davidson. This is where we highlight what…
The Market Online Video

Friday’s HotCopper Trends: Dreadnought taps investors, Tivan moves closer to JV | March 28, 2025

The ASX has been up 0.36% at 7,997 points this morning.